Although loss of p53 function is considered critical for the molecular pathogenesis of USPC (Moll et al, 1996), it is only recently that abnormality of the Rb pathway has been suggested to define a subgroup of aggressive endometrial carcinomas with poor prognosis (Salvesen et al, 2000). This evidence concerns the gene TP53 and endometrial carcinoma.